Date: 8.2.2016
Purdue University researchers participated in a multi-institute project that sequenced the genome of the common bedbug, a blood-sucking insect that has reemerged globally as a hardy pest capable of withstanding most major classes of insecticides.
The genome of Cimex lectularius uncovers the genetic underpinning of bedbugs' unique biology and offers new targets for controlling them. Purdue entomologists Ameya Gondhalekar and Michael Scharf contributed to the international effort by annotating the bugs' antioxidant genes, which detoxify the blood they ingest and likely play a role in disarming certain types of insecticides.
"Bedbugs were the ignored pests for many decades, but their sudden prevalence has sparked interest in developing better bedbug control measures and knowing more about their biology," said Gondhalekar, assistant professor of entomology. "The genome provides a much-needed platform for answering these questions at a deeper level."
Bedbugs have plagued humans for at least three thousand years, emerging at night to feed on blood, their sole source of nutrition and water. Widespread use of insecticides in homes after World War II curtailed their numbers dramatically, but over the past two decades, the bedbug has rebounded from near eradication in many regions to extraordinary levels of infestation on every continent except Antarctica. Infestations in Australia alone have risen 4,500 percent.
The bug's unexpected comeback is likely due to a surge in international travel, the exchange of secondhand goods and the pest's evolution of resistance to many conventional insecticides, said Scharf.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Animal Biotechnology - Animals, animal biotech
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Creek survey uncovers bacteriophages that could combat superbugs
Suspended animation drug could buy time in medical emergencies